Simvastatin Market 2027 By Mechanism, Dosage Form, Distribution Channel and Geography | The Insight Partners

Simvastatin Market to 2027 - Global Analysis and Forecasts By Mechanism (Enzymatic Synthesis, Chemical Synthesis); Dosage Form (Tablets, Capsules); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00006206 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Simvastatin is one of the lipid-lowering agent that is synthetically derived from the fermentation of Aspergillus terreus. Simvastatin is a rate-limiting enzyme that assists in cholesterol biosynthesis. Simvastatin also helps in cholesterol biosynthesis and interferes in steroid hormone production.

MARKET DYNAMICS

The simvastatin market is anticipated to grow in the forecast, owing to rising incidence of coronary heart diseases such as heart attack, strokes, atherosclerosis and others. In addition, the innovative R&D approaches incorporated by market players to develop effective and advanced drugs is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Simvastatin Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of simvastatin market with detailed market segmentation by mechanism, dosage form, distribution channel and geography. The global simvastatin market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading simvastatin market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global simvastatin market is segmented on the basis of mechanism, dosage form and distribution channel. Based on product, the market is segmented as, enzymatic synthesis and chemical synthesis. Based on dosage form, the market is segmented in to tablets and capsules. On the basis of distribution channel, the simvastatin market is categorized as hospital pharmacies, retail pharmacies and online pharmacies others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global simvastatin market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The simvastatin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting simvastatin market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the simvastatin market in these regions.

MARKET PLAYERS

The reports cover key developments in the simvastatin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from simvastatin market are anticipated to lucrative growth opportunities in the future with the rising demand for simvastatin market in the global market. Below mentioned is the list of few companies engaged in the simvastatin market.

The report also includes the profiles of key simvastatin market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Pfizer Inc.
- AstraZeneca Plc
- Novartis AG
- Merck KGaA
- Biocon
- GlaxoSmithKline Plc.
- Abbott
- Aurobindo Pharma
- Concord Biotech
- Sun Pharmaceutical Industries Ltd.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Simvastatin Market - By Mechanism
1.3.2 Simvastatin Market - By Dosage Form
1.3.3 Simvastatin Market - By Distribution Channel
1.3.4 Simvastatin Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SIMVASTATIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SIMVASTATIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SIMVASTATIN MARKET - GLOBAL MARKET ANALYSIS
6.1. SIMVASTATIN - GLOBAL MARKET OVERVIEW
6.2. SIMVASTATIN - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. SIMVASTATIN MARKET - REVENUE AND FORECASTS TO 2027 - MECHANISM
7.1. OVERVIEW
7.2. MECHANISM MARKET FORECASTS AND ANALYSIS
7.3. ENZYMATIC SYNTHESIS
7.3.1. Overview
7.3.2. Enzymatic Synthesis Market Forecast and Analysis
7.4. CHEMICAL SYNTHESIS
7.4.1. Overview
7.4.2. Chemical Synthesis Market Forecast and Analysis
8. SIMVASTATIN MARKET - REVENUE AND FORECASTS TO 2027 - DOSAGE FORM
8.1. OVERVIEW
8.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
8.3. TABLETS
8.3.1. Overview
8.3.2. Tablets Market Forecast and Analysis
8.4. CAPSULES
8.4.1. Overview
8.4.2. Capsules Market Forecast and Analysis
9. SIMVASTATIN MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. SIMVASTATIN MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Simvastatin Market Overview
10.1.2 North America Simvastatin Market Forecasts and Analysis
10.1.3 North America Simvastatin Market Forecasts and Analysis - By Mechanism
10.1.4 North America Simvastatin Market Forecasts and Analysis - By Dosage Form
10.1.5 North America Simvastatin Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Simvastatin Market Forecasts and Analysis - By Countries
10.1.6.1 United States Simvastatin Market
10.1.6.1.1 United States Simvastatin Market by Mechanism
10.1.6.1.2 United States Simvastatin Market by Dosage Form
10.1.6.1.3 United States Simvastatin Market by Distribution Channel
10.1.6.2 Canada Simvastatin Market
10.1.6.2.1 Canada Simvastatin Market by Mechanism
10.1.6.2.2 Canada Simvastatin Market by Dosage Form
10.1.6.2.3 Canada Simvastatin Market by Distribution Channel
10.1.6.3 Mexico Simvastatin Market
10.1.6.3.1 Mexico Simvastatin Market by Mechanism
10.1.6.3.2 Mexico Simvastatin Market by Dosage Form
10.1.6.3.3 Mexico Simvastatin Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Simvastatin Market Overview
10.2.2 Europe Simvastatin Market Forecasts and Analysis
10.2.3 Europe Simvastatin Market Forecasts and Analysis - By Mechanism
10.2.4 Europe Simvastatin Market Forecasts and Analysis - By Dosage Form
10.2.5 Europe Simvastatin Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Simvastatin Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Simvastatin Market
10.2.6.1.1 Germany Simvastatin Market by Mechanism
10.2.6.1.2 Germany Simvastatin Market by Dosage Form
10.2.6.1.3 Germany Simvastatin Market by Distribution Channel
10.2.6.2 France Simvastatin Market
10.2.6.2.1 France Simvastatin Market by Mechanism
10.2.6.2.2 France Simvastatin Market by Dosage Form
10.2.6.2.3 France Simvastatin Market by Distribution Channel
10.2.6.3 Italy Simvastatin Market
10.2.6.3.1 Italy Simvastatin Market by Mechanism
10.2.6.3.2 Italy Simvastatin Market by Dosage Form
10.2.6.3.3 Italy Simvastatin Market by Distribution Channel
10.2.6.4 Spain Simvastatin Market
10.2.6.4.1 Spain Simvastatin Market by Mechanism
10.2.6.4.2 Spain Simvastatin Market by Dosage Form
10.2.6.4.3 Spain Simvastatin Market by Distribution Channel
10.2.6.5 United Kingdom Simvastatin Market
10.2.6.5.1 United Kingdom Simvastatin Market by Mechanism
10.2.6.5.2 United Kingdom Simvastatin Market by Dosage Form
10.2.6.5.3 United Kingdom Simvastatin Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Simvastatin Market Overview
10.3.2 Asia-Pacific Simvastatin Market Forecasts and Analysis
10.3.3 Asia-Pacific Simvastatin Market Forecasts and Analysis - By Mechanism
10.3.4 Asia-Pacific Simvastatin Market Forecasts and Analysis - By Dosage Form
10.3.5 Asia-Pacific Simvastatin Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Simvastatin Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Simvastatin Market
10.3.6.1.1 Australia Simvastatin Market by Mechanism
10.3.6.1.2 Australia Simvastatin Market by Dosage Form
10.3.6.1.3 Australia Simvastatin Market by Distribution Channel
10.3.6.2 China Simvastatin Market
10.3.6.2.1 China Simvastatin Market by Mechanism
10.3.6.2.2 China Simvastatin Market by Dosage Form
10.3.6.2.3 China Simvastatin Market by Distribution Channel
10.3.6.3 India Simvastatin Market
10.3.6.3.1 India Simvastatin Market by Mechanism
10.3.6.3.2 India Simvastatin Market by Dosage Form
10.3.6.3.3 India Simvastatin Market by Distribution Channel
10.3.6.4 Japan Simvastatin Market
10.3.6.4.1 Japan Simvastatin Market by Mechanism
10.3.6.4.2 Japan Simvastatin Market by Dosage Form
10.3.6.4.3 Japan Simvastatin Market by Distribution Channel
10.3.6.5 South Korea Simvastatin Market
10.3.6.5.1 South Korea Simvastatin Market by Mechanism
10.3.6.5.2 South Korea Simvastatin Market by Dosage Form
10.3.6.5.3 South Korea Simvastatin Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Simvastatin Market Overview
10.4.2 Middle East and Africa Simvastatin Market Forecasts and Analysis
10.4.3 Middle East and Africa Simvastatin Market Forecasts and Analysis - By Mechanism
10.4.4 Middle East and Africa Simvastatin Market Forecasts and Analysis - By Dosage Form
10.4.5 Middle East and Africa Simvastatin Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Simvastatin Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Simvastatin Market
10.4.6.1.1 South Africa Simvastatin Market by Mechanism
10.4.6.1.2 South Africa Simvastatin Market by Dosage Form
10.4.6.1.3 South Africa Simvastatin Market by Distribution Channel
10.4.6.2 Saudi Arabia Simvastatin Market
10.4.6.2.1 Saudi Arabia Simvastatin Market by Mechanism
10.4.6.2.2 Saudi Arabia Simvastatin Market by Dosage Form
10.4.6.2.3 Saudi Arabia Simvastatin Market by Distribution Channel
10.4.6.3 U.A.E Simvastatin Market
10.4.6.3.1 U.A.E Simvastatin Market by Mechanism
10.4.6.3.2 U.A.E Simvastatin Market by Dosage Form
10.4.6.3.3 U.A.E Simvastatin Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Simvastatin Market Overview
10.5.2 South and Central America Simvastatin Market Forecasts and Analysis
10.5.3 South and Central America Simvastatin Market Forecasts and Analysis - By Mechanism
10.5.4 South and Central America Simvastatin Market Forecasts and Analysis - By Dosage Form
10.5.5 South and Central America Simvastatin Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Simvastatin Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Simvastatin Market
10.5.6.1.1 Brazil Simvastatin Market by Mechanism
10.5.6.1.2 Brazil Simvastatin Market by Dosage Form
10.5.6.1.3 Brazil Simvastatin Market by Distribution Channel
10.5.6.2 Argentina Simvastatin Market
10.5.6.2.1 Argentina Simvastatin Market by Mechanism
10.5.6.2.2 Argentina Simvastatin Market by Dosage Form
10.5.6.2.3 Argentina Simvastatin Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. SIMVASTATIN MARKET, KEY COMPANY PROFILES
12.1. PFIZER INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASTRAZENECA PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MERCK KGAA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BIOCON
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GLAXOSMITHKLINE PLC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ABBOTT
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. AUROBINDO PHARMA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. CONCORD BIOTECH
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SUN PHARMACEUTICAL INDUSTRIES LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer Inc.
2. AstraZeneca Plc
3. Novartis AG
4. Merck KGaA
5. Biocon
6. GlaxoSmithKline Plc.
7. Abbott
8. Aurobindo Pharma
9. Concord Biotech
10. Sun Pharmaceutical Industries Ltd.